European companies are heavily dependent on China, where many supply chains are simply paralysed because of the novel lung disease. The supply of spare parts from China to the world market has also stalled. A domino effect could occur. There goes the fear of not getting the medication you need. This is because active ingredients are manufactured in China and India in particular.
So far it should not come, more expensive available drugs may also be given out. In the pharmaceutical industry, besides the availability of active ingredients, processing is also an important issue. This is where EnWave's drying technology comes in. The company thereby enables lower weight, reduced shipping costs and cooling can be avoided.
For example, EnWave was able to conclude contracts with representatives of the pharmaceutical and biotech industries for its freeze-drying systems: https://www.commodity-tv.com/play/enwave-targeting-profitability-in-2020-signed-joint-development-deal-with-gea-lyophil/. Customers from the food industry also use EnWave's REV™ technology, as do manufacturers of medical cannabis.
But there is also good news, whether in terms of basic pensions or that the purchase of electric vehicles and plug-in hybrids will now even be subsidised retroactively (vehicles registered from 4 November) with an environmental bonus of up to 6,000 euros. Lithium-ion batteries are installed in these vehicles. Lithium is therefore a sought-after raw material.
One company that specializes in lithium is Millennial Lithium - https://www.commodity-tv.com/play/millennial-lithium-getting-environmental-permits-and-financing-until-summer/. The debt-free company has already received four out of five mining licenses for its Pastos Grandes Lithium Project. These licences cover 6,447 hectares of land. This is located in Argentina, where high quality lithium is available.
Current company information and press releases from Millennial Lithium (https://www.resource-capital.ch/en/companies/millennial-lithium-corp/) and EnWave (https://www.resource-capital.ch/en/companies/enwave-corp/).
In accordance with §34 WpHG I would like to point out that partners, authors and employees may hold shares in the respective companies addressed and thus a possible conflict of interest exists. No guarantee for the translation into English. Only the German version of this news is valid.
Disclaimer: The information provided does not represent any form of recommendation or advice. Express reference is made to the risks in securities trading. No liability can be accepted for any damage arising from the use of this blog. I would like to point out that shares and especially warrant investments are always associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. Despite the greatest care, I expressly reserve the right to make errors, especially with regard to figures and prices. The information contained herein is taken from sources believed to be reliable, but in no way claims to be accurate or complete. Due to court decisions, the contents of linked external sites are also co-responsible (e.g. Landgericht Hamburg, in the decision of 12.05.1998 - 312 O 85/98), as long as there is no explicit dissociation from them. Despite careful control of the content, I do not assume liability for the content of linked external pages. The respective operators are exclusively responsible for their content. The disclaimer of Swiss Resource Capital AG also
applies: https://www.resource-capital.ch/en/disclaimer/
